Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy
Clinical trial NCT06680479 · SUSPENDED
Trial details
- NCT number
- NCT06680479
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2027-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.